Are you looking for fast access to regulatory-grade clinical data in breast cancer? The comprehensive datasets within LynxCare’s European hospital network offer fresh insights into breast cancer, including comorbidity factors, treatment patterns, and staging.

With over 4800 estimated patients and 598 endpoints measured throughout the patient pathway, the granular and quality-controlled real-world datasets can unlock invaluable insights into the treatment and prognosis of breast cancer patients.

Click below and read more about the data sources, the representativeness of the dataset, the value of unstructured data, and how LynxCare's dataset stands out from the competition.

➡ CLICK HERE

‍

* LynxCare datasets concern datasets within the LynxCare hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.